Our new eBook brings together a special collection of recent Medicine Maker articles exploring oral dosage innovation, API stability, nitrosamine testing, greener delivery, and the changing demands shaping small molecule development.
The collection opens with a look at API stability, examining how stress testing and predictive tools can help developers anticipate degradation pathways, improve formulation decisions, and build more robust medicines from the earliest stages of development.
Contributors also explore the continuing evolution of softgels, including phthalate-free approaches powered by glycerin and sorbitol, as well as the practical challenges of managing formulation changes in Europe.
And in a feature on nitrosamine testing, experts from industry, regulatory science, and standards organizations discuss how the field is tackling ultra-trace detection, NDSRIs, API-excipient interactions, sample preparation, and evolving expectations for risk assessment and control.
Download the eBook for free. And if you have expertise or thought leadership to share in oral dosage, formulation, quality, manufacturing, or small molecule development, get in touch.
Download the eBook
